首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >2018 update of the EULAR recommendations for the management of hand osteoarthritis
【24h】

2018 update of the EULAR recommendations for the management of hand osteoarthritis

机译:2018年更新用于管理骨关节炎的欧元建议

获取原文
获取原文并翻译 | 示例
           

摘要

Since publication of the European League Against Rheumatism (EULAR) recommendations for management of hand osteoarthritis (OA) in 2007 new evidence has emerged. The aim was to update these recommendations. EULAR standardised operating procedures were followed. A systematic literature review was performed, collecting the evidence regarding all non-pharmacological, pharmacological and surgical treatment options for hand OA published to date. Based on the evidence and expert opinion from an international task force of 19 physicians, healthcare professionals and patients from 10 European countries formulated overarching principles and recommendations. Level of evidence, grade of recommendation and level of agreement were allocated to each statement. Five overarching principles and 10 recommendations were agreed on. The overarching principles cover treatment goals, information provision, individualisation of treatment, shared decision-making and the need to consider multidisciplinary and multimodal (non-pharmacological, pharmacological, surgical) treatment approaches. Recommendations 1-3 cover different non-pharmacological treatment options (education, assistive devices, exercises and orthoses). Recommendations 4-8 describe the role of different pharmacological treatments, including topical treatments (preferred over systemic treatments, topical non-steroidal anti-inflammatory drugs (NSAIDs) being first-line choice), oral analgesics (particularly NSAIDs to be considered for symptom relief for a limited duration), chondroitin sulfate (for symptom relief), intra-articular glucocorticoids (generally not recommended, consider for painful interphalangeal OA) and conventional/biological disease-modifying antirheumatic drugs (discouraged). Considerations for surgery are described in recommendation 9. The last recommendation relates to follow-up. The presented EULAR recommendations provide up-to-date guidance on the management of hand OA, based on expert opinion and research evidence.
机译:自2007年出版欧洲联盟对欧洲联盟(欧元)对动手骨关节炎(OA)的建议进行了新的证据。目的是更新这些建议。遵循欧元标准化的操作程序。进行了系统的文献综述,收集了关于迄今为止发布的武器OA的所有非药理,药理和手术治疗方案的证据。基于来自19名医生的国际特遣部队的证据和专家意见,医疗保健专业人员和来自10个欧洲国家的患者制定了总体原则和建议。每个陈述分配给每个陈述的证据水平,建议等级和协议水平。达成了五项总体原则和10项建议。总体原则涵盖治疗目标,信息规定,待遇的个性化,共享决策以及需要考虑多学科和多式联运(非药理学,药理学,外科手术)治疗方法。建议1-3涵盖不同的非药理学治疗方案(教育,辅助设备,练习和矫形器)。建议4-8描述了不同药理治疗的作用,包括局部处理(优选全身治疗,局部非甾体类抗炎药(NSAID)是一线选择),口腔镇痛药(特别是被认为是症状浮雕的NSAIDs对于有限的持续时间),硫酸软骨素(用于症状缓解),关节内糖皮质激素(通常不推荐,考虑痛苦的间骨膜OA)和常规/生物疾病改性的抗胃肿药物(气馁)。建议9中描述了手术的注意事项。最后建议与随访有关。卓越的欧元建议提供关于手工oA管理的最新指导,基于专家意见和研究证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号